⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28444039 | 0.97 | — | — | |
| Methane SCHEMBL28352715 | 0.97 | — | — | |
| SCHEMBL6056256 | 0.81 | — | — | |
| SCHEMBL104481 | 0.79 | — | — | |
| SCHEMBL2254698 | 0.77 | — | — | |
| SCHEMBL15855949 | 0.76 | HIF1A (0.43) | — | |
| Bromide SCHEMBL4189519 | 0.76 | — | — | |
| SCHEMBL31047466 | 0.76 | — | — | |
| SCHEMBL2035218 | 0.76 | HIF1A (0.43) | — | |
| Hydrochloric Acid SCHEMBL19547768 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106317126-B | Benzene oxygen 2- imine imidazole alkane metal complex and its preparation method and application | 东华大学 | 2019-01-15 | — | — | CN | claimed |
| CN-106317126-A | Phenoxy-2-iminoimidazolidine metal complex and preparation method and application thereof | 东华大学 | 2017-01-11 | — | — | CN | claimed |
| EP-1730205-B1 | POLIMERIZATION CATALYST COMPRISING AN AMIDINE LIGAND | LANXESS ELASTOMERS BV (NL) | 2012-09-26 | — | — | EP | claimed |
| US-20100256132-A1 | IL-12 MODULATORY COMPOUNDS | SYNTA PHARMACEUTICALS CORPORATION (US) | 2010-10-07 | — | — | US | claimed |
| EP-1765325-A4 | 2-SUBSTITUTED HETEROARYL COMPOUNDS | SYNTA PHARMACEUTICALS CORP (US) | 2009-08-12 | — | — | EP | claimed |
| US-20090012246-A1 | Polymerization Catalyst Comprising Amidine Ligand | DMS IP ASSETS B.V. (NL) | 2009-01-08 | — | — | US | claimed |
| JP-2007529584-A | — | — | 2007-10-25 | — | — | JP | claimed |
| WO-2007100759-A2 | METHOD FOR TREATING COMMON VARIABLE IMMUNODEFICIENCY | SYNTA PHARMACEUTICALS CORP. (US) | 2007-09-07 | — | — | WO | claimed |
| EP-1819341-A2 | IL-12 MODULATORY COMPOUNDS | Synta Pharmaceuticals Corporation (US) | 2007-08-22 | — | — | EP | claimed |
| EP-1765325-A2 | 2-SUBSTITUTED HETEROARYL COMPOUNDS | Synta Pharmaceuticals Corporation (US) | 2007-03-28 | — | — | EP | claimed |
| US-20060063739-A1 | 2-Substituted heteroaryl compounds | LSI FINANCING LLC, AS ADMINISTRATIVE AGENT | 2006-03-23 | — | — | US | claimed |
| WO-2006007532-A2 | 2-SUBSTITUTED HETEROARYL COMPOUNDS | SYNTA PHARMACEUTICALS CORP. (US) | 2006-01-19 | — | — | WO | claimed |
| WO-2005090418-A1 | POLIMERIZATION CATALYST COMPRISING AN AMIDINE LIGAND | DSM IP ASSETS B.V. (NL) | 2005-09-29 | — | — | WO | claimed |
| EP-1412327-A2 | INHIBITORS OF PROTEIN KINASE FOR THE TREATMENT OF DISEASE | LG Biomedical Institute (US) | 2004-04-28 | — | — | EP | claimed |
| US-20030187007-A1 | Inhibitors of protein kinase for the treatment of disease | LG BIOMEDICAL INSTITUTE | 2003-10-02 | — | — | US | claimed |
| WO-2002096867-A2 | INHIBITORS OF PROTEIN KINASE FOR THE TREATMENT OF DISEASE | LG BIOMEDICAL INSTITUTE (US) | 2002-12-05 | — | — | WO | claimed |
| US-5512588-A | ANTIULCER AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-30 | — | — | US | claimed |
| EP-0107306-B1 | IMIDAZOLINE DERIVATIVES | BEECHAM GROUP PLC (GB) | 1986-04-30 | — | — | EP | claimed |
| US-4505926-A | GASTROINTESTINAL DISORDERS ANTIDIARRHEA | BEECHAM GROUP P.L.C. (GB) | 1985-03-19 | — | — | US | claimed |
| EP-0107306-A1 | Imidazoline derivatives | BEECHAM GROUP PLC (GB) | 1984-05-02 | — | — | EP | claimed |